Microbial‐derived lithocholic acid and vitamin K2 drive the metabolic maturation of pluripotent stem cells–derived and fetal hepatocytes

The liver is the main organ responsible for the modification, clearance, and transformational toxicity of most xenobiotics owing to its abundance in cytochrome P450 (CYP450) enzymes. However, the scarcity and variability of primary hepatocytes currently limits their utility. Human pluripotent stem cells (hPSCs) represent an excellent source of differentiated hepatocytes; however, current protocols still produce fetal‐like hepatocytes with limited mature function. Interestingly, fetal hepatocytes acquire mature CYP450 expression only postpartum, suggesting that nutritional cues may drive hepatic maturation. We show that vitamin K2 and lithocholic acid, a by‐product of intestinal flora, activate pregnane X receptor (PXR) and subsequent CYP3A4 and CYP2C9 expression in hPSC‐derived and isolated fetal hepatocytes. Differentiated cells produce albumin and apolipoprotein B100 at levels equivalent to primary human hepatocytes, while demonstrating an 8‐fold induction of CYP450 activity in response to aryl hydrocarbon receptor (AhR) agonist omeprazole and a 10‐fold induction in response to PXR agonist rifampicin. Flow cytometry showed that over 83% of cells were albumin and hepatocyte nuclear factor 4 alpha (HNF4α) positive, permitting high‐content screening in a 96‐well plate format. Analysis of 12 compounds showed an R2 correlation of 0.94 between TC50 values obtained in stem cell–derived hepatocytes and primary cells, compared to 0.62 for HepG2 cells. Finally, stem cell–derived hepatocytes demonstrate all toxicological endpoints examined, including steatosis, apoptosis, and cholestasis, when exposed to nine known hepatotoxins. Conclusion: Our work provides fresh insights into liver development, suggesting that microbial‐derived cues may drive the maturation of CYP450 enzymes postpartum. Addition of these cues results in the first functional, inducible, hPSC‐derived hepatocyte for predictive toxicology. (Hepatology 2015;62:265‐278)

[1]  L. Benet,et al.  Mouse liver repopulation with hepatocytes generated from human fibroblasts , 2014, Nature.

[2]  John P Iredale,et al.  Embryonic Stem Cells / Induced Pluripotent Stem ( iPS ) Cells Accurate Prediction of Drug-Induced Liver Injury Using Stem Cell-Derived Populations , 2014 .

[3]  J. Schellens,et al.  Milk Thistle’s Active Components Silybin and Isosilybin: Novel Inhibitors of PXR-Mediated CYP3A4 Induction , 2013, Drug Metabolism and Disposition.

[4]  Takanori Takebe,et al.  Vascularized and functional human liver from an iPSC-derived organ bud transplant , 2013, Nature.

[5]  Philip Roelandt,et al.  Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus. , 2012, Journal of hepatology.

[6]  Hung-Chih Kuo,et al.  Rapid generation of mature hepatocyte‐like cells from human induced pluripotent stem cells by an efficient three‐step protocol , 2012, Hepatology.

[7]  J. Glenn,et al.  Transdifferentiation of adipose‐derived stem cells into hepatocytes: a new approach , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[8]  J. Itskovitz‐Eldor,et al.  Suspension Culture of Undifferentiated Human Embryonic and Induced Pluripotent Stem Cells , 2010, Stem Cell Reviews and Reports.

[9]  M. Yarmush,et al.  Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism. , 2010, Journal of hepatology.

[10]  M. Zern,et al.  Differentiation and Characterization of Metabolically Functioning Hepatocytes from Human Embryonic Stem Cells , 2010, Stem cells.

[11]  B. Christ,et al.  The generation of hepatocytes from mesenchymal stem cells and engraftment into murine liver* , 2010, Nature Protocols.

[12]  Stephen Dalton,et al.  Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells , 2010, Hepatology.

[13]  M. Yarmush,et al.  Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance , 2009, Proceedings of the National Academy of Sciences.

[14]  Xiaolei Yin,et al.  Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells , 2009, Cell Research.

[15]  M. Shearer.  Vitamin K deficiency bleeding (VKDB) in early infancy. , 2009, Blood reviews.

[16]  L. Morelli.  Postnatal development of intestinal microflora as influenced by infant nutrition. , 2008, The Journal of nutrition.

[17]  Hayley S. Brown,et al.  Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies , 2007, Drug metabolism reviews.

[18]  M. Yarmush,et al.  Integration of technologies for hepatic tissue engineering. , 2006, Advances in biochemical engineering/biotechnology.

[19]  K. Horie-Inoue,et al.  Steroid and Xenobiotic Receptor SXR Mediates Vitamin K2-activated Transcription of Extracellular Matrix-related Genes and Collagen Accumulation in Osteoblastic Cells*♦ , 2006, Journal of Biological Chemistry.

[20]  G. Macfarlane,et al.  Characterisation of intestinal bacteria in infant stools using real-time PCR and northern hybridisation analyses. , 2005, FEMS microbiology ecology.

[21]  Neil Kaplowitz,et al.  Idiosyncratic drug hepatotoxicity , 2005, Nature Reviews Drug Discovery.

[22]  M. T. Donato,et al.  Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[23]  B. Blumberg,et al.  Vitamin K2 Regulation of Bone Homeostasis Is Mediated by the Steroid and Xenobiotic Receptor SXR* , 2003, Journal of Biological Chemistry.

[24]  R. Schwartz,et al.  Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. , 2002, The Journal of clinical investigation.

[25]  E L LeCluyse,et al.  Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[26]  C Helma,et al.  Data quality in predictive toxicology: reproducibility of rodent carcinogenicity experiments. , 2001, Environmental health perspectives.

[27]  T. Willson,et al.  The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Miyajima,et al.  Oncostatin M and hepatocyte growth factor induce hepatic maturation via distinct signaling pathways , 2001, FEBS letters.

[29]  J A Thomson,et al.  Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. , 2000, Developmental biology.

[30]  S. Bhatia,et al.  Xenobiotic metabolism by cultured primary porcine hepatocytes. , 2000, Tissue engineering.

[31]  P Smith,et al.  Concordance of the toxicity of pharmaceuticals in humans and in animals. , 2000, Regulatory toxicology and pharmacology : RTP.

[32]  B. Goodwin,et al.  The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. , 1999, Molecular pharmacology.

[33]  M. Makishima,et al.  Identification of a nuclear receptor for bile acids. , 1999, Science.

[34]  A. Guillouzo,et al.  Liver cell models in in vitro toxicology. , 1998, Environmental health perspectives.

[35]  T. Cresteil,et al.  Expression of CYP3A in the human liver--evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth. , 1997, European journal of biochemistry.

[36]  J. Conly,et al.  The production of menaquinones (vitamin K2) by intestinal bacteria and their role in maintaining coagulation homeostasis. , 1992, Progress in food & nutrition science.

[37]  M. Shearer,et al.  PLASMA VITAMIN K1 IN MOTHERS AND THEIR NEWBORN BABIES , 1982, The Lancet.

[38]  S. Haydu,et al.  PEAK-FLOW METER v. PEAK-FLOW GAUGE , 1974 .

[39]  Yaakov Nahmias,et al.  Long-term culture and coculture of primary rat and human hepatocytes. , 2013, Methods in molecular biology.

[40]  Philip Roelandt,et al.  Directed differentiation of pluripotent stem cells to functional hepatocytes. , 2013, Methods in molecular biology.

[41]  F. Guengerich.  Cytochrome p450 and chemical toxicology. , 2008, Chemical research in toxicology.

[42]  S. Bhatia,et al.  Microscale culture of human liver cells for drug development , 2008, Nature Biotechnology.

[43]  P. Kero,et al.  Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. , 1999, Journal of pediatric gastroenterology and nutrition.